01
Major Shareholders (Top 10)
Top 10 shareholders with shareholding ratio
April 16, 2024
|
CURRENT SHAREHOLDING
|
SHARES
|
%
|
|---|---|---|
|
Tong-Hsuan Chang
|
4,309,092 |
3.97%
|
| The representative of Taiwan Advanced Biopharma Inc.: Wen-Long, Su |
3,122,919
287,271 |
2.88%
0.26% |
| The investment portfolios of Otsuka Pharmaceutical Co., Ltd. Entrust and manage by Mega International Commercial Bank |
3,036,000
|
2.80%
|
| Hsiu E. Su |
2,204,489
|
2.03%
|
| Kun-Chang, Li |
2,065,000
|
1.90%
|
| Huarong, Lian |
1,496,000
|
1.38%
|
| Cai -Qing Hong |
1,326,485
|
1.22%
|
| The representative of Rong Jing Development Investment Co., Ltd.: Shu-Fen, Jiang |
1,152,000
187,000 |
1.06%
0.17% |
| The investment portfolios of Sui Feng Co., Ltd. entrust and manage by BANK SINOPAC COMPANY LIMITEDk |
1,122,256
|
1.03%
|
| Jing-Yang, Chen |
985,000
|
0.91%
|
03
Annual Reports
04
Market Observation Post System
本公司依規定，將不定期、即時揭露「重大訊息」於公開資訊觀測站。
可連結至公開資訊觀測站並請輸入「台灣醣聯生技醫藥股份有限公司」代號 ( 4168 )
本公司依規定，將不定期、即時揭露「股利分派情形」於公開資訊觀測站。
可連結至公開資訊觀測站並請輸入「台灣醣聯生技醫藥股份有限公司」代號 ( 4168 )